Global Brain and Central Nervous System Cancer Treatments Market Growth 2026-2032
The global Brain and Central Nervous System Cancer Treatments market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Tumors in the brain and spinal cord are called central nervous system (CNS) tumors. These tumors occur when abnormal cells form in any part of the brain or spine area. A tumor may be benign, meaning it does not have cancer cells, or malignant, meaning cancer is present.
United States market for Brain and Central Nervous System Cancer Treatments is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Brain and Central Nervous System Cancer Treatments is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Brain and Central Nervous System Cancer Treatments is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Brain and Central Nervous System Cancer Treatments players cover Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Brain and Central Nervous System Cancer Treatments Industry Forecast? looks at past sales and reviews total world Brain and Central Nervous System Cancer Treatments sales in 2025, providing a comprehensive analysis by region and market sector of projected Brain and Central Nervous System Cancer Treatments sales for 2026 through 2032. With Brain and Central Nervous System Cancer Treatments sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Brain and Central Nervous System Cancer Treatments industry.
This Insight Report provides a comprehensive analysis of the global Brain and Central Nervous System Cancer Treatments landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Brain and Central Nervous System Cancer Treatments portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Brain and Central Nervous System Cancer Treatments market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Brain and Central Nervous System Cancer Treatments and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Brain and Central Nervous System Cancer Treatments.
This report presents a comprehensive overview, market shares, and growth opportunities of Brain and Central Nervous System Cancer Treatments market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tumors in the brain and spinal cord are called central nervous system (CNS) tumors. These tumors occur when abnormal cells form in any part of the brain or spine area. A tumor may be benign, meaning it does not have cancer cells, or malignant, meaning cancer is present.
United States market for Brain and Central Nervous System Cancer Treatments is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Brain and Central Nervous System Cancer Treatments is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Brain and Central Nervous System Cancer Treatments is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Brain and Central Nervous System Cancer Treatments players cover Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Brain and Central Nervous System Cancer Treatments Industry Forecast? looks at past sales and reviews total world Brain and Central Nervous System Cancer Treatments sales in 2025, providing a comprehensive analysis by region and market sector of projected Brain and Central Nervous System Cancer Treatments sales for 2026 through 2032. With Brain and Central Nervous System Cancer Treatments sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Brain and Central Nervous System Cancer Treatments industry.
This Insight Report provides a comprehensive analysis of the global Brain and Central Nervous System Cancer Treatments landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Brain and Central Nervous System Cancer Treatments portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Brain and Central Nervous System Cancer Treatments market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Brain and Central Nervous System Cancer Treatments and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Brain and Central Nervous System Cancer Treatments.
This report presents a comprehensive overview, market shares, and growth opportunities of Brain and Central Nervous System Cancer Treatments market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Chemotherapy
- Targeted Therapy
- Immunotherapy (Biologic Therapy)
- Hormonal Therapy
- Others
- Brain Cancer
- Spinal Cord Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Celgene
- Novartis
- Bristol-Myers Squibb
- Johnson & Johnson
- Merck & Co.
- AstraZeneca
- Pfizer
- Amgen
- Eli Lilly
- AbbVie
- Takeda
- Astellas
- Ipsen
- Sanofi
- Bayer
- Biogen Idec
- Teva
- Otsuka
- Eisai
- Merck KGaA
- Gilead Sciences
- What is the 10-year outlook for the global Brain and Central Nervous System Cancer Treatments market?
- What factors are driving Brain and Central Nervous System Cancer Treatments market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Brain and Central Nervous System Cancer Treatments market opportunities vary by end market size?
- How does Brain and Central Nervous System Cancer Treatments break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Brain and Central Nervous System Cancer Treatments Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Brain and Central Nervous System Cancer Treatments by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Brain and Central Nervous System Cancer Treatments by Country/Region, 2021, 2025 & 2032
2.2 Brain and Central Nervous System Cancer Treatments Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy (Biologic Therapy)
2.2.4 Hormonal Therapy
2.2.5 Others
2.2.6 Brain and Central Nervous System Cancer Treatments Sales by Type
2.2.6.1 Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2026)
2.2.6.2 Global Brain and Central Nervous System Cancer Treatments Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Brain and Central Nervous System Cancer Treatments Sale Price by Type (2021-2026)
2.3 Brain and Central Nervous System Cancer Treatments Segment by Application
2.3.1 Brain Cancer
2.3.2 Spinal Cord Cancer
2.3.3 Others
2.3.4 Brain and Central Nervous System Cancer Treatments Sales by Application
2.3.4.1 Global Brain and Central Nervous System Cancer Treatments Sale Market Share by Application (2021-2026)
2.3.4.2 Global Brain and Central Nervous System Cancer Treatments Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Brain and Central Nervous System Cancer Treatments Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Brain and Central Nervous System Cancer Treatments Breakdown Data by Company
3.1.1 Global Brain and Central Nervous System Cancer Treatments Annual Sales by Company (2021-2026)
3.1.2 Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Company (2021-2026)
3.2 Global Brain and Central Nervous System Cancer Treatments Annual Revenue by Company (2021-2026)
3.2.1 Global Brain and Central Nervous System Cancer Treatments Revenue by Company (2021-2026)
3.2.2 Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Company (2021-2026)
3.3 Global Brain and Central Nervous System Cancer Treatments Sale Price by Company
3.4 Key Manufacturers Brain and Central Nervous System Cancer Treatments Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Brain and Central Nervous System Cancer Treatments Product Location Distribution
3.4.2 Players Brain and Central Nervous System Cancer Treatments Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BRAIN AND CENTRAL NERVOUS SYSTEM CANCER TREATMENTS BY GEOGRAPHIC REGION
4.1 World Historic Brain and Central Nervous System Cancer Treatments Market Size by Geographic Region (2021-2026)
4.1.1 Global Brain and Central Nervous System Cancer Treatments Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Brain and Central Nervous System Cancer Treatments Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Brain and Central Nervous System Cancer Treatments Market Size by Country/Region (2021-2026)
4.2.1 Global Brain and Central Nervous System Cancer Treatments Annual Sales by Country/Region (2021-2026)
4.2.2 Global Brain and Central Nervous System Cancer Treatments Annual Revenue by Country/Region (2021-2026)
4.3 Americas Brain and Central Nervous System Cancer Treatments Sales Growth
4.4 APAC Brain and Central Nervous System Cancer Treatments Sales Growth
4.5 Europe Brain and Central Nervous System Cancer Treatments Sales Growth
4.6 Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales Growth
5 AMERICAS
5.1 Americas Brain and Central Nervous System Cancer Treatments Sales by Country
5.1.1 Americas Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026)
5.1.2 Americas Brain and Central Nervous System Cancer Treatments Revenue by Country (2021-2026)
5.2 Americas Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026)
5.3 Americas Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Brain and Central Nervous System Cancer Treatments Sales by Region
6.1.1 APAC Brain and Central Nervous System Cancer Treatments Sales by Region (2021-2026)
6.1.2 APAC Brain and Central Nervous System Cancer Treatments Revenue by Region (2021-2026)
6.2 APAC Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026)
6.3 APAC Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Brain and Central Nervous System Cancer Treatments by Country
7.1.1 Europe Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026)
7.1.2 Europe Brain and Central Nervous System Cancer Treatments Revenue by Country (2021-2026)
7.2 Europe Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026)
7.3 Europe Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Brain and Central Nervous System Cancer Treatments by Country
8.1.1 Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026)
8.1.2 Middle East & Africa Brain and Central Nervous System Cancer Treatments Revenue by Country (2021-2026)
8.2 Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026)
8.3 Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Brain and Central Nervous System Cancer Treatments
10.3 Manufacturing Process Analysis of Brain and Central Nervous System Cancer Treatments
10.4 Industry Chain Structure of Brain and Central Nervous System Cancer Treatments
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Brain and Central Nervous System Cancer Treatments Distributors
11.3 Brain and Central Nervous System Cancer Treatments Customer
12 WORLD FORECAST REVIEW FOR BRAIN AND CENTRAL NERVOUS SYSTEM CANCER TREATMENTS BY GEOGRAPHIC REGION
12.1 Global Brain and Central Nervous System Cancer Treatments Market Size Forecast by Region
12.1.1 Global Brain and Central Nervous System Cancer Treatments Forecast by Region (2027-2032)
12.1.2 Global Brain and Central Nervous System Cancer Treatments Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Brain and Central Nervous System Cancer Treatments Forecast by Type (2027-2032)
12.7 Global Brain and Central Nervous System Cancer Treatments Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.1.3 Roche Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Celgene
13.2.1 Celgene Company Information
13.2.2 Celgene Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.2.3 Celgene Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Celgene Main Business Overview
13.2.5 Celgene Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.3.3 Novartis Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Information
13.4.2 Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.4.3 Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bristol-Myers Squibb Main Business Overview
13.4.5 Bristol-Myers Squibb Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.5.3 Johnson & Johnson Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Merck & Co.
13.6.1 Merck & Co. Company Information
13.6.2 Merck & Co. Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.6.3 Merck & Co. Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Merck & Co. Main Business Overview
13.6.5 Merck & Co. Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.7.3 AstraZeneca Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.8.3 Pfizer Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Amgen
13.9.1 Amgen Company Information
13.9.2 Amgen Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.9.3 Amgen Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Amgen Main Business Overview
13.9.5 Amgen Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.10.3 Eli Lilly Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 AbbVie
13.11.1 AbbVie Company Information
13.11.2 AbbVie Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.11.3 AbbVie Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 AbbVie Main Business Overview
13.11.5 AbbVie Latest Developments
13.12 Takeda
13.12.1 Takeda Company Information
13.12.2 Takeda Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.12.3 Takeda Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Takeda Main Business Overview
13.12.5 Takeda Latest Developments
13.13 Astellas
13.13.1 Astellas Company Information
13.13.2 Astellas Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.13.3 Astellas Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Astellas Main Business Overview
13.13.5 Astellas Latest Developments
13.14 Ipsen
13.14.1 Ipsen Company Information
13.14.2 Ipsen Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.14.3 Ipsen Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Ipsen Main Business Overview
13.14.5 Ipsen Latest Developments
13.15 Sanofi
13.15.1 Sanofi Company Information
13.15.2 Sanofi Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.15.3 Sanofi Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sanofi Main Business Overview
13.15.5 Sanofi Latest Developments
13.16 Bayer
13.16.1 Bayer Company Information
13.16.2 Bayer Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.16.3 Bayer Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Bayer Main Business Overview
13.16.5 Bayer Latest Developments
13.17 Biogen Idec
13.17.1 Biogen Idec Company Information
13.17.2 Biogen Idec Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.17.3 Biogen Idec Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Biogen Idec Main Business Overview
13.17.5 Biogen Idec Latest Developments
13.18 Teva
13.18.1 Teva Company Information
13.18.2 Teva Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.18.3 Teva Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Teva Main Business Overview
13.18.5 Teva Latest Developments
13.19 Otsuka
13.19.1 Otsuka Company Information
13.19.2 Otsuka Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.19.3 Otsuka Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Otsuka Main Business Overview
13.19.5 Otsuka Latest Developments
13.20 Eisai
13.20.1 Eisai Company Information
13.20.2 Eisai Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.20.3 Eisai Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Eisai Main Business Overview
13.20.5 Eisai Latest Developments
13.21 Merck KGaA
13.21.1 Merck KGaA Company Information
13.21.2 Merck KGaA Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.21.3 Merck KGaA Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Merck KGaA Main Business Overview
13.21.5 Merck KGaA Latest Developments
13.22 Gilead Sciences
13.22.1 Gilead Sciences Company Information
13.22.2 Gilead Sciences Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.22.3 Gilead Sciences Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Gilead Sciences Main Business Overview
13.22.5 Gilead Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Brain and Central Nervous System Cancer Treatments Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Brain and Central Nervous System Cancer Treatments by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Brain and Central Nervous System Cancer Treatments by Country/Region, 2021, 2025 & 2032
2.2 Brain and Central Nervous System Cancer Treatments Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy (Biologic Therapy)
2.2.4 Hormonal Therapy
2.2.5 Others
2.2.6 Brain and Central Nervous System Cancer Treatments Sales by Type
2.2.6.1 Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2026)
2.2.6.2 Global Brain and Central Nervous System Cancer Treatments Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Brain and Central Nervous System Cancer Treatments Sale Price by Type (2021-2026)
2.3 Brain and Central Nervous System Cancer Treatments Segment by Application
2.3.1 Brain Cancer
2.3.2 Spinal Cord Cancer
2.3.3 Others
2.3.4 Brain and Central Nervous System Cancer Treatments Sales by Application
2.3.4.1 Global Brain and Central Nervous System Cancer Treatments Sale Market Share by Application (2021-2026)
2.3.4.2 Global Brain and Central Nervous System Cancer Treatments Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Brain and Central Nervous System Cancer Treatments Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Brain and Central Nervous System Cancer Treatments Breakdown Data by Company
3.1.1 Global Brain and Central Nervous System Cancer Treatments Annual Sales by Company (2021-2026)
3.1.2 Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Company (2021-2026)
3.2 Global Brain and Central Nervous System Cancer Treatments Annual Revenue by Company (2021-2026)
3.2.1 Global Brain and Central Nervous System Cancer Treatments Revenue by Company (2021-2026)
3.2.2 Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Company (2021-2026)
3.3 Global Brain and Central Nervous System Cancer Treatments Sale Price by Company
3.4 Key Manufacturers Brain and Central Nervous System Cancer Treatments Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Brain and Central Nervous System Cancer Treatments Product Location Distribution
3.4.2 Players Brain and Central Nervous System Cancer Treatments Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BRAIN AND CENTRAL NERVOUS SYSTEM CANCER TREATMENTS BY GEOGRAPHIC REGION
4.1 World Historic Brain and Central Nervous System Cancer Treatments Market Size by Geographic Region (2021-2026)
4.1.1 Global Brain and Central Nervous System Cancer Treatments Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Brain and Central Nervous System Cancer Treatments Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Brain and Central Nervous System Cancer Treatments Market Size by Country/Region (2021-2026)
4.2.1 Global Brain and Central Nervous System Cancer Treatments Annual Sales by Country/Region (2021-2026)
4.2.2 Global Brain and Central Nervous System Cancer Treatments Annual Revenue by Country/Region (2021-2026)
4.3 Americas Brain and Central Nervous System Cancer Treatments Sales Growth
4.4 APAC Brain and Central Nervous System Cancer Treatments Sales Growth
4.5 Europe Brain and Central Nervous System Cancer Treatments Sales Growth
4.6 Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales Growth
5 AMERICAS
5.1 Americas Brain and Central Nervous System Cancer Treatments Sales by Country
5.1.1 Americas Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026)
5.1.2 Americas Brain and Central Nervous System Cancer Treatments Revenue by Country (2021-2026)
5.2 Americas Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026)
5.3 Americas Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Brain and Central Nervous System Cancer Treatments Sales by Region
6.1.1 APAC Brain and Central Nervous System Cancer Treatments Sales by Region (2021-2026)
6.1.2 APAC Brain and Central Nervous System Cancer Treatments Revenue by Region (2021-2026)
6.2 APAC Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026)
6.3 APAC Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Brain and Central Nervous System Cancer Treatments by Country
7.1.1 Europe Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026)
7.1.2 Europe Brain and Central Nervous System Cancer Treatments Revenue by Country (2021-2026)
7.2 Europe Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026)
7.3 Europe Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Brain and Central Nervous System Cancer Treatments by Country
8.1.1 Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026)
8.1.2 Middle East & Africa Brain and Central Nervous System Cancer Treatments Revenue by Country (2021-2026)
8.2 Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026)
8.3 Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Brain and Central Nervous System Cancer Treatments
10.3 Manufacturing Process Analysis of Brain and Central Nervous System Cancer Treatments
10.4 Industry Chain Structure of Brain and Central Nervous System Cancer Treatments
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Brain and Central Nervous System Cancer Treatments Distributors
11.3 Brain and Central Nervous System Cancer Treatments Customer
12 WORLD FORECAST REVIEW FOR BRAIN AND CENTRAL NERVOUS SYSTEM CANCER TREATMENTS BY GEOGRAPHIC REGION
12.1 Global Brain and Central Nervous System Cancer Treatments Market Size Forecast by Region
12.1.1 Global Brain and Central Nervous System Cancer Treatments Forecast by Region (2027-2032)
12.1.2 Global Brain and Central Nervous System Cancer Treatments Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Brain and Central Nervous System Cancer Treatments Forecast by Type (2027-2032)
12.7 Global Brain and Central Nervous System Cancer Treatments Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.1.3 Roche Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Celgene
13.2.1 Celgene Company Information
13.2.2 Celgene Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.2.3 Celgene Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Celgene Main Business Overview
13.2.5 Celgene Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.3.3 Novartis Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Information
13.4.2 Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.4.3 Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bristol-Myers Squibb Main Business Overview
13.4.5 Bristol-Myers Squibb Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.5.3 Johnson & Johnson Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Merck & Co.
13.6.1 Merck & Co. Company Information
13.6.2 Merck & Co. Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.6.3 Merck & Co. Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Merck & Co. Main Business Overview
13.6.5 Merck & Co. Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.7.3 AstraZeneca Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.8.3 Pfizer Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Amgen
13.9.1 Amgen Company Information
13.9.2 Amgen Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.9.3 Amgen Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Amgen Main Business Overview
13.9.5 Amgen Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.10.3 Eli Lilly Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 AbbVie
13.11.1 AbbVie Company Information
13.11.2 AbbVie Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.11.3 AbbVie Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 AbbVie Main Business Overview
13.11.5 AbbVie Latest Developments
13.12 Takeda
13.12.1 Takeda Company Information
13.12.2 Takeda Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.12.3 Takeda Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Takeda Main Business Overview
13.12.5 Takeda Latest Developments
13.13 Astellas
13.13.1 Astellas Company Information
13.13.2 Astellas Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.13.3 Astellas Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Astellas Main Business Overview
13.13.5 Astellas Latest Developments
13.14 Ipsen
13.14.1 Ipsen Company Information
13.14.2 Ipsen Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.14.3 Ipsen Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Ipsen Main Business Overview
13.14.5 Ipsen Latest Developments
13.15 Sanofi
13.15.1 Sanofi Company Information
13.15.2 Sanofi Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.15.3 Sanofi Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sanofi Main Business Overview
13.15.5 Sanofi Latest Developments
13.16 Bayer
13.16.1 Bayer Company Information
13.16.2 Bayer Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.16.3 Bayer Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Bayer Main Business Overview
13.16.5 Bayer Latest Developments
13.17 Biogen Idec
13.17.1 Biogen Idec Company Information
13.17.2 Biogen Idec Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.17.3 Biogen Idec Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Biogen Idec Main Business Overview
13.17.5 Biogen Idec Latest Developments
13.18 Teva
13.18.1 Teva Company Information
13.18.2 Teva Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.18.3 Teva Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Teva Main Business Overview
13.18.5 Teva Latest Developments
13.19 Otsuka
13.19.1 Otsuka Company Information
13.19.2 Otsuka Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.19.3 Otsuka Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Otsuka Main Business Overview
13.19.5 Otsuka Latest Developments
13.20 Eisai
13.20.1 Eisai Company Information
13.20.2 Eisai Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.20.3 Eisai Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Eisai Main Business Overview
13.20.5 Eisai Latest Developments
13.21 Merck KGaA
13.21.1 Merck KGaA Company Information
13.21.2 Merck KGaA Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.21.3 Merck KGaA Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Merck KGaA Main Business Overview
13.21.5 Merck KGaA Latest Developments
13.22 Gilead Sciences
13.22.1 Gilead Sciences Company Information
13.22.2 Gilead Sciences Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
13.22.3 Gilead Sciences Brain and Central Nervous System Cancer Treatments Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Gilead Sciences Main Business Overview
13.22.5 Gilead Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Brain and Central Nervous System Cancer Treatments Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Brain and Central Nervous System Cancer Treatments Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Chemotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Immunotherapy (Biologic Therapy)
Table 6. Major Players of Hormonal Therapy
Table 7. Major Players of Others
Table 8. Global Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units)
Table 9. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2026)
Table 10. Global Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2026) & ($ million)
Table 11. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Type (2021-2026)
Table 12. Global Brain and Central Nervous System Cancer Treatments Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Brain and Central Nervous System Cancer Treatments Sale by Application (2021-2026) & (K Units)
Table 14. Global Brain and Central Nervous System Cancer Treatments Sale Market Share by Application (2021-2026)
Table 15. Global Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2026) & ($ million)
Table 16. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Application (2021-2026)
Table 17. Global Brain and Central Nervous System Cancer Treatments Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Brain and Central Nervous System Cancer Treatments Sales by Company (2021-2026) & (K Units)
Table 19. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Company (2021-2026)
Table 20. Global Brain and Central Nervous System Cancer Treatments Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Company (2021-2026)
Table 22. Global Brain and Central Nervous System Cancer Treatments Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Brain and Central Nervous System Cancer Treatments Producing Area Distribution and Sales Area
Table 24. Players Brain and Central Nervous System Cancer Treatments Products Offered
Table 25. Brain and Central Nervous System Cancer Treatments Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Brain and Central Nervous System Cancer Treatments Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Brain and Central Nervous System Cancer Treatments Sales Market Share Geographic Region (2021-2026)
Table 30. Global Brain and Central Nervous System Cancer Treatments Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Brain and Central Nervous System Cancer Treatments Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Country/Region (2021-2026)
Table 34. Global Brain and Central Nervous System Cancer Treatments Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units)
Table 37. Americas Brain and Central Nervous System Cancer Treatments Sales Market Share by Country (2021-2026)
Table 38. Americas Brain and Central Nervous System Cancer Treatments Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units)
Table 40. Americas Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units)
Table 41. APAC Brain and Central Nervous System Cancer Treatments Sales by Region (2021-2026) & (K Units)
Table 42. APAC Brain and Central Nervous System Cancer Treatments Sales Market Share by Region (2021-2026)
Table 43. APAC Brain and Central Nervous System Cancer Treatments Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units)
Table 45. APAC Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units)
Table 46. Europe Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units)
Table 47. Europe Brain and Central Nervous System Cancer Treatments Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units)
Table 49. Europe Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Brain and Central Nervous System Cancer Treatments Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Brain and Central Nervous System Cancer Treatments
Table 55. Key Market Challenges & Risks of Brain and Central Nervous System Cancer Treatments
Table 56. Key Industry Trends of Brain and Central Nervous System Cancer Treatments
Table 57. Brain and Central Nervous System Cancer Treatments Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Brain and Central Nervous System Cancer Treatments Distributors List
Table 60. Brain and Central Nervous System Cancer Treatments Customer List
Table 61. Global Brain and Central Nervous System Cancer Treatments Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Brain and Central Nervous System Cancer Treatments Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Brain and Central Nervous System Cancer Treatments Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Brain and Central Nervous System Cancer Treatments Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Brain and Central Nervous System Cancer Treatments Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Brain and Central Nervous System Cancer Treatments Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Brain and Central Nervous System Cancer Treatments Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Brain and Central Nervous System Cancer Treatments Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Brain and Central Nervous System Cancer Treatments Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Brain and Central Nervous System Cancer Treatments Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Brain and Central Nervous System Cancer Treatments Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Roche Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 76. Roche Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 77. Roche Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Roche Main Business
Table 79. Roche Latest Developments
Table 80. Celgene Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 81. Celgene Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 82. Celgene Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Celgene Main Business
Table 84. Celgene Latest Developments
Table 85. Novartis Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 86. Novartis Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 87. Novartis Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Novartis Main Business
Table 89. Novartis Latest Developments
Table 90. Bristol-Myers Squibb Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 91. Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 92. Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Bristol-Myers Squibb Main Business
Table 94. Bristol-Myers Squibb Latest Developments
Table 95. Johnson & Johnson Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 96. Johnson & Johnson Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 97. Johnson & Johnson Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Johnson & Johnson Main Business
Table 99. Johnson & Johnson Latest Developments
Table 100. Merck & Co. Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 101. Merck & Co. Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 102. Merck & Co. Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Merck & Co. Main Business
Table 104. Merck & Co. Latest Developments
Table 105. AstraZeneca Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 106. AstraZeneca Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 107. AstraZeneca Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. AstraZeneca Main Business
Table 109. AstraZeneca Latest Developments
Table 110. Pfizer Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 111. Pfizer Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 112. Pfizer Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Pfizer Main Business
Table 114. Pfizer Latest Developments
Table 115. Amgen Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 116. Amgen Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 117. Amgen Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Amgen Main Business
Table 119. Amgen Latest Developments
Table 120. Eli Lilly Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 121. Eli Lilly Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 122. Eli Lilly Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Eli Lilly Main Business
Table 124. Eli Lilly Latest Developments
Table 125. AbbVie Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 126. AbbVie Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 127. AbbVie Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. AbbVie Main Business
Table 129. AbbVie Latest Developments
Table 130. Takeda Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 131. Takeda Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 132. Takeda Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Takeda Main Business
Table 134. Takeda Latest Developments
Table 135. Astellas Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 136. Astellas Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 137. Astellas Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Astellas Main Business
Table 139. Astellas Latest Developments
Table 140. Ipsen Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 141. Ipsen Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 142. Ipsen Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Ipsen Main Business
Table 144. Ipsen Latest Developments
Table 145. Sanofi Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 146. Sanofi Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 147. Sanofi Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Sanofi Main Business
Table 149. Sanofi Latest Developments
Table 150. Bayer Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 151. Bayer Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 152. Bayer Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Bayer Main Business
Table 154. Bayer Latest Developments
Table 155. Biogen Idec Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 156. Biogen Idec Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 157. Biogen Idec Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Biogen Idec Main Business
Table 159. Biogen Idec Latest Developments
Table 160. Teva Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 161. Teva Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 162. Teva Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Teva Main Business
Table 164. Teva Latest Developments
Table 165. Otsuka Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 166. Otsuka Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 167. Otsuka Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Otsuka Main Business
Table 169. Otsuka Latest Developments
Table 170. Eisai Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 171. Eisai Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 172. Eisai Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. Eisai Main Business
Table 174. Eisai Latest Developments
Table 175. Merck KGaA Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 176. Merck KGaA Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 177. Merck KGaA Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Merck KGaA Main Business
Table 179. Merck KGaA Latest Developments
Table 180. Gilead Sciences Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 181. Gilead Sciences Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 182. Gilead Sciences Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 183. Gilead Sciences Main Business
Table 184. Gilead Sciences Latest Developments
Table 1. Brain and Central Nervous System Cancer Treatments Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Brain and Central Nervous System Cancer Treatments Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Chemotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Immunotherapy (Biologic Therapy)
Table 6. Major Players of Hormonal Therapy
Table 7. Major Players of Others
Table 8. Global Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units)
Table 9. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2026)
Table 10. Global Brain and Central Nervous System Cancer Treatments Revenue by Type (2021-2026) & ($ million)
Table 11. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Type (2021-2026)
Table 12. Global Brain and Central Nervous System Cancer Treatments Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Brain and Central Nervous System Cancer Treatments Sale by Application (2021-2026) & (K Units)
Table 14. Global Brain and Central Nervous System Cancer Treatments Sale Market Share by Application (2021-2026)
Table 15. Global Brain and Central Nervous System Cancer Treatments Revenue by Application (2021-2026) & ($ million)
Table 16. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Application (2021-2026)
Table 17. Global Brain and Central Nervous System Cancer Treatments Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Brain and Central Nervous System Cancer Treatments Sales by Company (2021-2026) & (K Units)
Table 19. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Company (2021-2026)
Table 20. Global Brain and Central Nervous System Cancer Treatments Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Company (2021-2026)
Table 22. Global Brain and Central Nervous System Cancer Treatments Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Brain and Central Nervous System Cancer Treatments Producing Area Distribution and Sales Area
Table 24. Players Brain and Central Nervous System Cancer Treatments Products Offered
Table 25. Brain and Central Nervous System Cancer Treatments Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Brain and Central Nervous System Cancer Treatments Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Brain and Central Nervous System Cancer Treatments Sales Market Share Geographic Region (2021-2026)
Table 30. Global Brain and Central Nervous System Cancer Treatments Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Brain and Central Nervous System Cancer Treatments Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Country/Region (2021-2026)
Table 34. Global Brain and Central Nervous System Cancer Treatments Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units)
Table 37. Americas Brain and Central Nervous System Cancer Treatments Sales Market Share by Country (2021-2026)
Table 38. Americas Brain and Central Nervous System Cancer Treatments Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units)
Table 40. Americas Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units)
Table 41. APAC Brain and Central Nervous System Cancer Treatments Sales by Region (2021-2026) & (K Units)
Table 42. APAC Brain and Central Nervous System Cancer Treatments Sales Market Share by Region (2021-2026)
Table 43. APAC Brain and Central Nervous System Cancer Treatments Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units)
Table 45. APAC Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units)
Table 46. Europe Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units)
Table 47. Europe Brain and Central Nervous System Cancer Treatments Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units)
Table 49. Europe Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Brain and Central Nervous System Cancer Treatments Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Brain and Central Nervous System Cancer Treatments
Table 55. Key Market Challenges & Risks of Brain and Central Nervous System Cancer Treatments
Table 56. Key Industry Trends of Brain and Central Nervous System Cancer Treatments
Table 57. Brain and Central Nervous System Cancer Treatments Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Brain and Central Nervous System Cancer Treatments Distributors List
Table 60. Brain and Central Nervous System Cancer Treatments Customer List
Table 61. Global Brain and Central Nervous System Cancer Treatments Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Brain and Central Nervous System Cancer Treatments Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Brain and Central Nervous System Cancer Treatments Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Brain and Central Nervous System Cancer Treatments Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Brain and Central Nervous System Cancer Treatments Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Brain and Central Nervous System Cancer Treatments Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Brain and Central Nervous System Cancer Treatments Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Brain and Central Nervous System Cancer Treatments Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Brain and Central Nervous System Cancer Treatments Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Brain and Central Nervous System Cancer Treatments Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Brain and Central Nervous System Cancer Treatments Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Roche Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 76. Roche Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 77. Roche Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Roche Main Business
Table 79. Roche Latest Developments
Table 80. Celgene Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 81. Celgene Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 82. Celgene Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Celgene Main Business
Table 84. Celgene Latest Developments
Table 85. Novartis Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 86. Novartis Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 87. Novartis Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Novartis Main Business
Table 89. Novartis Latest Developments
Table 90. Bristol-Myers Squibb Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 91. Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 92. Bristol-Myers Squibb Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Bristol-Myers Squibb Main Business
Table 94. Bristol-Myers Squibb Latest Developments
Table 95. Johnson & Johnson Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 96. Johnson & Johnson Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 97. Johnson & Johnson Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Johnson & Johnson Main Business
Table 99. Johnson & Johnson Latest Developments
Table 100. Merck & Co. Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 101. Merck & Co. Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 102. Merck & Co. Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Merck & Co. Main Business
Table 104. Merck & Co. Latest Developments
Table 105. AstraZeneca Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 106. AstraZeneca Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 107. AstraZeneca Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. AstraZeneca Main Business
Table 109. AstraZeneca Latest Developments
Table 110. Pfizer Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 111. Pfizer Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 112. Pfizer Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Pfizer Main Business
Table 114. Pfizer Latest Developments
Table 115. Amgen Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 116. Amgen Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 117. Amgen Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Amgen Main Business
Table 119. Amgen Latest Developments
Table 120. Eli Lilly Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 121. Eli Lilly Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 122. Eli Lilly Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Eli Lilly Main Business
Table 124. Eli Lilly Latest Developments
Table 125. AbbVie Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 126. AbbVie Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 127. AbbVie Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. AbbVie Main Business
Table 129. AbbVie Latest Developments
Table 130. Takeda Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 131. Takeda Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 132. Takeda Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Takeda Main Business
Table 134. Takeda Latest Developments
Table 135. Astellas Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 136. Astellas Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 137. Astellas Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Astellas Main Business
Table 139. Astellas Latest Developments
Table 140. Ipsen Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 141. Ipsen Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 142. Ipsen Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Ipsen Main Business
Table 144. Ipsen Latest Developments
Table 145. Sanofi Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 146. Sanofi Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 147. Sanofi Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Sanofi Main Business
Table 149. Sanofi Latest Developments
Table 150. Bayer Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 151. Bayer Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 152. Bayer Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Bayer Main Business
Table 154. Bayer Latest Developments
Table 155. Biogen Idec Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 156. Biogen Idec Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 157. Biogen Idec Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Biogen Idec Main Business
Table 159. Biogen Idec Latest Developments
Table 160. Teva Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 161. Teva Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 162. Teva Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Teva Main Business
Table 164. Teva Latest Developments
Table 165. Otsuka Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 166. Otsuka Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 167. Otsuka Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Otsuka Main Business
Table 169. Otsuka Latest Developments
Table 170. Eisai Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 171. Eisai Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 172. Eisai Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. Eisai Main Business
Table 174. Eisai Latest Developments
Table 175. Merck KGaA Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 176. Merck KGaA Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 177. Merck KGaA Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Merck KGaA Main Business
Table 179. Merck KGaA Latest Developments
Table 180. Gilead Sciences Basic Information, Brain and Central Nervous System Cancer Treatments Manufacturing Base, Sales Area and Its Competitors
Table 181. Gilead Sciences Brain and Central Nervous System Cancer Treatments Product Portfolios and Specifications
Table 182. Gilead Sciences Brain and Central Nervous System Cancer Treatments Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 183. Gilead Sciences Main Business
Table 184. Gilead Sciences Latest Developments
LIST OF FIGURES
Figure 1. Picture of Brain and Central Nervous System Cancer Treatments
Figure 2. Brain and Central Nervous System Cancer Treatments Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Brain and Central Nervous System Cancer Treatments Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Brain and Central Nervous System Cancer Treatments Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Brain and Central Nervous System Cancer Treatments Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Brain and Central Nervous System Cancer Treatments Sales Market Share by Country/Region (2025)
Figure 10. Brain and Central Nervous System Cancer Treatments Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Chemotherapy
Figure 12. Product Picture of Targeted Therapy
Figure 13. Product Picture of Immunotherapy (Biologic Therapy)
Figure 14. Product Picture of Hormonal Therapy
Figure 15. Product Picture of Others
Figure 16. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Type in 2026
Figure 17. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Type (2021-2026)
Figure 18. Brain and Central Nervous System Cancer Treatments Consumed in Brain Cancer
Figure 19. Global Brain and Central Nervous System Cancer Treatments Market: Brain Cancer (2021-2026) & (K Units)
Figure 20. Brain and Central Nervous System Cancer Treatments Consumed in Spinal Cord Cancer
Figure 21. Global Brain and Central Nervous System Cancer Treatments Market: Spinal Cord Cancer (2021-2026) & (K Units)
Figure 22. Brain and Central Nervous System Cancer Treatments Consumed in Others
Figure 23. Global Brain and Central Nervous System Cancer Treatments Market: Others (2021-2026) & (K Units)
Figure 24. Global Brain and Central Nervous System Cancer Treatments Sale Market Share by Application (2025)
Figure 25. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Application in 2026
Figure 26. Brain and Central Nervous System Cancer Treatments Sales by Company in 2026 (K Units)
Figure 27. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Company in 2026
Figure 28. Brain and Central Nervous System Cancer Treatments Revenue by Company in 2026 ($ millions)
Figure 29. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Company in 2026
Figure 30. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Brain and Central Nervous System Cancer Treatments Sales 2021-2026 (K Units)
Figure 33. Americas Brain and Central Nervous System Cancer Treatments Revenue 2021-2026 ($ millions)
Figure 34. APAC Brain and Central Nervous System Cancer Treatments Sales 2021-2026 (K Units)
Figure 35. APAC Brain and Central Nervous System Cancer Treatments Revenue 2021-2026 ($ millions)
Figure 36. Europe Brain and Central Nervous System Cancer Treatments Sales 2021-2026 (K Units)
Figure 37. Europe Brain and Central Nervous System Cancer Treatments Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Brain and Central Nervous System Cancer Treatments Revenue 2021-2026 ($ millions)
Figure 40. Americas Brain and Central Nervous System Cancer Treatments Sales Market Share by Country in 2026
Figure 41. Americas Brain and Central Nervous System Cancer Treatments Revenue Market Share by Country (2021-2026)
Figure 42. Americas Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2026)
Figure 43. Americas Brain and Central Nervous System Cancer Treatments Sales Market Share by Application (2021-2026)
Figure 44. United States Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Brain and Central Nervous System Cancer Treatments Sales Market Share by Region in 2026
Figure 49. APAC Brain and Central Nervous System Cancer Treatments Revenue Market Share by Region (2021-2026)
Figure 50. APAC Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2026)
Figure 51. APAC Brain and Central Nervous System Cancer Treatments Sales Market Share by Application (2021-2026)
Figure 52. China Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 56. India Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Brain and Central Nervous System Cancer Treatments Sales Market Share by Country in 2026
Figure 60. Europe Brain and Central Nervous System Cancer Treatments Revenue Market Share by Country (2021-2026)
Figure 61. Europe Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2026)
Figure 62. Europe Brain and Central Nervous System Cancer Treatments Sales Market Share by Application (2021-2026)
Figure 63. Germany Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 64. France Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales Market Share by Application (2021-2026)
Figure 71. Egypt Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Brain and Central Nervous System Cancer Treatments in 2026
Figure 77. Manufacturing Process Analysis of Brain and Central Nervous System Cancer Treatments
Figure 78. Industry Chain Structure of Brain and Central Nervous System Cancer Treatments
Figure 79. Channels of Distribution
Figure 80. Global Brain and Central Nervous System Cancer Treatments Sales Market Forecast by Region (2027-2032)
Figure 81. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Brain and Central Nervous System Cancer Treatments Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Brain and Central Nervous System Cancer Treatments Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Brain and Central Nervous System Cancer Treatments
Figure 2. Brain and Central Nervous System Cancer Treatments Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Brain and Central Nervous System Cancer Treatments Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Brain and Central Nervous System Cancer Treatments Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Brain and Central Nervous System Cancer Treatments Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Brain and Central Nervous System Cancer Treatments Sales Market Share by Country/Region (2025)
Figure 10. Brain and Central Nervous System Cancer Treatments Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Chemotherapy
Figure 12. Product Picture of Targeted Therapy
Figure 13. Product Picture of Immunotherapy (Biologic Therapy)
Figure 14. Product Picture of Hormonal Therapy
Figure 15. Product Picture of Others
Figure 16. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Type in 2026
Figure 17. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Type (2021-2026)
Figure 18. Brain and Central Nervous System Cancer Treatments Consumed in Brain Cancer
Figure 19. Global Brain and Central Nervous System Cancer Treatments Market: Brain Cancer (2021-2026) & (K Units)
Figure 20. Brain and Central Nervous System Cancer Treatments Consumed in Spinal Cord Cancer
Figure 21. Global Brain and Central Nervous System Cancer Treatments Market: Spinal Cord Cancer (2021-2026) & (K Units)
Figure 22. Brain and Central Nervous System Cancer Treatments Consumed in Others
Figure 23. Global Brain and Central Nervous System Cancer Treatments Market: Others (2021-2026) & (K Units)
Figure 24. Global Brain and Central Nervous System Cancer Treatments Sale Market Share by Application (2025)
Figure 25. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Application in 2026
Figure 26. Brain and Central Nervous System Cancer Treatments Sales by Company in 2026 (K Units)
Figure 27. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Company in 2026
Figure 28. Brain and Central Nervous System Cancer Treatments Revenue by Company in 2026 ($ millions)
Figure 29. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Company in 2026
Figure 30. Global Brain and Central Nervous System Cancer Treatments Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Brain and Central Nervous System Cancer Treatments Sales 2021-2026 (K Units)
Figure 33. Americas Brain and Central Nervous System Cancer Treatments Revenue 2021-2026 ($ millions)
Figure 34. APAC Brain and Central Nervous System Cancer Treatments Sales 2021-2026 (K Units)
Figure 35. APAC Brain and Central Nervous System Cancer Treatments Revenue 2021-2026 ($ millions)
Figure 36. Europe Brain and Central Nervous System Cancer Treatments Sales 2021-2026 (K Units)
Figure 37. Europe Brain and Central Nervous System Cancer Treatments Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Brain and Central Nervous System Cancer Treatments Revenue 2021-2026 ($ millions)
Figure 40. Americas Brain and Central Nervous System Cancer Treatments Sales Market Share by Country in 2026
Figure 41. Americas Brain and Central Nervous System Cancer Treatments Revenue Market Share by Country (2021-2026)
Figure 42. Americas Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2026)
Figure 43. Americas Brain and Central Nervous System Cancer Treatments Sales Market Share by Application (2021-2026)
Figure 44. United States Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Brain and Central Nervous System Cancer Treatments Sales Market Share by Region in 2026
Figure 49. APAC Brain and Central Nervous System Cancer Treatments Revenue Market Share by Region (2021-2026)
Figure 50. APAC Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2026)
Figure 51. APAC Brain and Central Nervous System Cancer Treatments Sales Market Share by Application (2021-2026)
Figure 52. China Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 56. India Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Brain and Central Nervous System Cancer Treatments Sales Market Share by Country in 2026
Figure 60. Europe Brain and Central Nervous System Cancer Treatments Revenue Market Share by Country (2021-2026)
Figure 61. Europe Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2026)
Figure 62. Europe Brain and Central Nervous System Cancer Treatments Sales Market Share by Application (2021-2026)
Figure 63. Germany Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 64. France Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Brain and Central Nervous System Cancer Treatments Sales Market Share by Application (2021-2026)
Figure 71. Egypt Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Brain and Central Nervous System Cancer Treatments Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Brain and Central Nervous System Cancer Treatments in 2026
Figure 77. Manufacturing Process Analysis of Brain and Central Nervous System Cancer Treatments
Figure 78. Industry Chain Structure of Brain and Central Nervous System Cancer Treatments
Figure 79. Channels of Distribution
Figure 80. Global Brain and Central Nervous System Cancer Treatments Sales Market Forecast by Region (2027-2032)
Figure 81. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Brain and Central Nervous System Cancer Treatments Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Brain and Central Nervous System Cancer Treatments Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Brain and Central Nervous System Cancer Treatments Revenue Market Share Forecast by Application (2027-2032)
